¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
3/2 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2024-03-01
Á¶È¸¼ö
79


¾È³çÇϼ¼¿ä.

À̹ø ÁÖ ¹ßÇ¥ÀÚ Áö¼öÀÔ´Ï´Ù.

Á¦°¡ À̹ø¿¡ ¹ßÇ¥ÇÒ ³í¹®Àº 2020³â Cell Host and Microbe¿¡ ÃâÆǵÈ
'Salmonella-Driven Polarization of Granuloma Macrophages Antagonizes TNF-Mediated Pathogen Restriction during Persistent Infection'ÀÔ´Ï´Ù.

Granuloma´Â ¿©·¯ inflammatory cellsÀÇ ÁýÇÕü·Î, persistent stimuli¿¡ ¹ÝÀÀÇÏ¿© antigen disseminationÀ» ¸·´Â host protectiveÇÑ ¿ªÇÒÀ» ¼öÇàÇÕ´Ï´Ù. ¹Ý´ë·Î, granuloma¸¦ ±¸¼ºÇÏ´Â macrophageÀÇ Æ¯¼º¿¡ µû¶ó, bacteria persistence¸¦ À§ÇÑ cellular niche¸¦ Á¦°øÇÏ´Â µî intracellular bacterial pathogens beneficialÇÑ ¿ªÇÒÀ» ¼öÇàÇÒ ¼ö ÀÖ½À´Ï´Ù.

À̸¦ ¹ÙÅÁÀ¸·Î º» ¿¬±¸¿¡¼­´Â Salmonella Typhimurium (STm) °¨¿° ½Ã¿¡ granuloma macrophage polarization¿Í pathogen persistenceÀÇ °ü°è¸¦ TNF signaling ¹× STm SteE¸¦ ÅëÇØ È®ÀÎÇß½À´Ï´Ù. °á°úÀûÀ¸·Î, TNF signalingÀÌ M2 granuloma macrophage polarizationÀ» Á¦ÇÑÇÔÀ¸·Î½á pathogen persistence¸¦ ¾ïÁ¦ÇÏ°í, STm SteE´Â M2 granuloma macrophage polarizationÀ» ÃËÁøÇÔÀ¸·Î½á TNF-mediated restrictionÀ» ±Øº¹ÇÑ´Ù´Â °ÍÀ» ¹àÇû½À´Ï´Ù.

¸ÕÀú, STm °¨¿° ½Ã¿¡ granuloma macrophage ¼ö°¡ Áõ°¡ÇÏ°í antimicrobial response¿¡ µû¶ó TNF ¿Í iNOS productionÀÌ Áõ°¡ÇÔÀ» È®ÀÎ Çß½À´Ï´Ù. ¶ÇÇÑ, M2 macrophage markerÀÎ CD301À» ÅëÇØ granuloma periphery À§Ä¡¿¡ CD301 positive populationÀ» È®ÀÎÇß°í À̵éÀÇ antimicrobial functionsÀÌ »ó´ëÀûÀ¸·Î ³·´Ù´Â °ÍÀ» È®ÀÎÇß½À´Ï´Ù.

´ÙÀ½À¸·Î, TNF neutralization ½Ã¿¡ granuloma macrophageÀÇ IL-4Rα expression, CD301 positive population, ±×¸®°í bacterial burdenÀÌ Áõ°¡ÇÏ´Â °ÍÀ» ÅëÇØ TNF signalingÀÌ M2 granuloma macrophage polarizationÀ» ¾ïÁ¦ÇÔÀ» È®ÀÎÇß°í, SteE mutant STm °¨¿° ½Ã¿¡´Â ÇØ´ç ¿äÀεéÀÌ °¨¼ÒÇÏ´Â °ÍÀ» ÅëÇØ STm SteE¸¦ ¸Å°³·Î M2 granuloma macrophage polarizationÀÌ À¯µµµÊÀ» È®ÀÎÇß½À´Ï´Ù.

À̸¦ ÅëÇØ STmÀÌ M2-like features·ÎÀÇ state º¯È­¸¦ À¯µµÇØ granuloma macrophage ³»¿¡¼­ persistent haborÇϸç, ÀÌ¿Í °ü·ÃÇÑ TNF ¹× SteEÀÇ ¹Ý´ëµÇ´Â ÀÛ¿ëÀ» ÅëÇØ macrophage polarizationÀ» Á¶ÀýÇÏ´Â °ÍÀÌ intracellular bacteria¿¡ ´ëÇ×ÇÏ´Â ÇϳªÀÇ Àü·«ÀÌ µÉ ¼ö ÀÖÀ½À» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù.

¿­½ÉÈ÷ ÁغñÇÏ¿© Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.

°¨»çÇÕ´Ï´Ù.

³í¹®¸µÅ© : https://www.sciencedirect.com/science/article/pii/S1931312819305931?via%3Dihub#bib34
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
3/9 ¹ßÇ¥ ³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, À̹ø ÁÖ ¹ßÇ¥ÀÚ ¿äÇÑÀÔ´Ï´Ù. Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº 2023³â 3¿ù Immunity¿¡ ÃâÆÇµÈ "Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection" ÀÔ´Ï´Ù. ÀӽŠ¹× ¼öÀ¯ ±â°£ Áß »ê¸ðÀÇ ½Ä´ÜÀº ÀÌÈÄ ÅÂ..
ÀÌÀü±Û
3/2 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, À̹ø ÁÖ ¹ßÇ¥ÀÚ µµºóÀÔ´Ï´Ù. À̹ø ¹ßÇ¥ ³í¹®Àº ÀÛ³â 12¿ù Cell metabolism ¿¡ ÃâÆÇµÈ 'GDF15 is a major determinant of ketogenic diet-induced weight loss' ÀÔ´Ï´Ù. Ketogenic diet (KD) Àúź¼öÈ­¹° °íÁö¹æ ½Ä´ÜÀ¸·Î ÃÖ±Ù ¿©·¯ Áúº´¿¡ Ä¡·á È¿°ú°¡ ÀÖ´Ù°í ¾Ë·ÁÁ® ÀÖÀ¸¸ç ƯÈ÷ üÁß °¨·®, gluc..